Toxicity, immunogenicity, and induction of E75-specific tumor-lytic CTLs by HER-2 peptide E75 (369-377) combined with granulocyte macrophage colony-stimulating factor in HLA-A2 patients with metastatic breast and ovarian cancer (Q52009428)
Jump to navigation
Jump to search
scientific article published in November 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Toxicity, immunogenicity, and induction of E75-specific tumor-lytic CTLs by HER-2 peptide E75 (369-377) combined with granulocyte macrophage colony-stimulating factor in HLA-A2 patients with metastatic breast and ovarian cancer |
scientific article published in November 2002 |
Statements
Toxicity, immunogenicity, and induction of E75-specific tumor-lytic CTLs by HER-2 peptide E75 (369-377) combined with granulocyte macrophage colony-stimulating factor in HLA-A2 patients with metastatic breast and ovarian cancer (English)
1 reference
Gabriel N Hortobagyi
1 reference
James L Murray
1 reference
Michael E Gillogly
1 reference
Donna Przepiorka
1 reference
Hannah Brewer
1 reference
Nuhad K Ibrahim
1 reference
Daniel J Booser
1 reference
Andrzej P Kudelka
1 reference
Kenneth H Grabstein
1 reference
Martin A Cheever
1 reference
Constantin G Ioannides
1 reference
1 November 2002
1 reference
8
1 reference
11
1 reference
3407-3418
1 reference